Actuate Therapeutics, Inc. (ACTU) stock
ACTUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.25−0.01 (-2.38%)
Close on Nov 18, 2026Market cap $5.90MP/E –Yield –
Actuate Therapeutics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Actuate Therapeutics's shares outstanding was 24M at Sep 30, 2026. For fiscal 2025 it was 21M, up 151.1% from the year before.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 21M | +151.1% |
| FY2024 | Dec 31, 2024 | 8M | +483.5% |
| FY2023 | Dec 31, 2023 | 1M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 24M | +13.2% |
| Q2 FY2026 | Jun 30, 2026 | 24M | +21.5% |
| Q1 FY2026 | Mar 31, 2026 | 24M | +20.7% |
| Q4 FY2025 | Dec 31, 2025 | 24M | +118.4% |
| Q3 FY2025 | Sep 30, 2025 | 21M | +1266.4% |
| Q2 FY2025 | Jun 30, 2025 | 20M | +1179.8% |
| Q1 FY2025 | Mar 31, 2025 | 19M | +1196.9% |
| Q3 FY2024 | Sep 30, 2024 | 11M | +631.7% |
| Q2 FY2024 | Jun 30, 2024 | 2M | +10.1% |
| Q1 FY2024 | Mar 31, 2024 | 2M | – |
| Q4 FY2023 | Dec 31, 2023 | 2M | – |
| Q3 FY2023 | Sep 30, 2023 | 1M | – |
| Q2 FY2023 | Jun 30, 2023 | 1M | – |
See a number that looks wrong?